MedPath
TGA Approval

BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI (339070)

339070

BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI

AstraZeneca Pty Ltd

July 19, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/0626ce7e2218c768b8f962c69feb8456.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/37fa4a0d484819efe8d3b4939bf17253.pdf

Active Ingredients

budesonide

formoterol fumarate dihydrate

glycopyrronium bromide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI (339070) - TGA 批准文号 | MedPath